Research Article
Patient Perspectives on the Use of Digital Technology to Help Manage Cystic Fibrosis
| Demographic information |
| Total patients, | 31 | Age at onboarding (years) | Mean (SD) | 33 (9.4) | Range | 18-58 | Female, (%) | 17 (54.8) | Primary insurance, (%) | Commercial | 25 (80.6) | Medicare | 4 (12.9) | Medicaid | 2 (6.5) | % predicted FEV1, mean (SD) | 68.3 (26.3) | Airway disease severity, (%) | Mild | 14 (45.2) | Moderate | 10 (32.3) | Severe | 7 (22.6) | Number of medications, mean (SD) | | 20 (5.6) | Comorbidities, (%) | Cystic fibrosis-related diabetes | 16 (51.6) | Liver disease | 5 (16.1) | Peptic ulcer disease | 1 (3.2) |
|
|
FEV1 = forced expiratory volume in one second; SD = standard deviation.
|